The University of Chicago Header Logo

Connection

Harriet De Wit to Dronabinol

Back to Details
This is a "connection" page, showing publications Harriet De Wit has written about Dronabinol.
Harriet De Wit
Connection Strength
10.022
Dronabinol
  1. Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine. Neuropsychopharmacology. 2024 Jun; 49(7):1120-1128.
    View in: PubMed
    Score: 0.859
  2. ?9-THC reduces reward-related brain activity in healthy adults. Psychopharmacology (Berl). 2022 Sep; 239(9):2829-2840.
    View in: PubMed
    Score: 0.765
  3. Effects of Oral Delta-9-Tetrahydrocannabinol in Women During the Follicular Phase of the Menstrual Cycle. Cannabis Cannabinoid Res. 2023 12; 8(6):1117-1125.
    View in: PubMed
    Score: 0.764
  4. Acute effects of oral delta-9-tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects. Psychophysiology. 2022 02; 59(2):e13955.
    View in: PubMed
    Score: 0.734
  5. ?9-Tetrahydrocannabinol (THC) impairs visual working memory performance: a randomized crossover trial. Neuropsychopharmacology. 2020 10; 45(11):1807-1816.
    View in: PubMed
    Score: 0.664
  6. ?9-Tetrahydrocannabinol During Encoding Impairs Perceptual Details yet Spares Context Effects on Episodic Memory. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 01; 5(1):110-118.
    View in: PubMed
    Score: 0.633
  7. Developing a phone-based measure of impairment after acute oral ?9-tetrahydrocannabinol. J Psychopharmacol. 2019 09; 33(9):1160-1169.
    View in: PubMed
    Score: 0.631
  8. ?9-Tetrahydrocannabinol at Retrieval Drives False Recollection of Neutral and Emotional Memories. Biol Psychiatry. 2018 11 15; 84(10):743-750.
    View in: PubMed
    Score: 0.578
  9. Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress. Drug Alcohol Depend. 2017 08 01; 177:136-144.
    View in: PubMed
    Score: 0.541
  10. A Preliminary Investigation of Individual Differences in Subjective Responses to D-Amphetamine, Alcohol, and Delta-9-Tetrahydrocannabinol Using a Within-Subjects Randomized Trial. PLoS One. 2015; 10(10):e0140501.
    View in: PubMed
    Score: 0.485
  11. Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans. Psychopharmacology (Berl). 2013 Apr; 226(3):515-29.
    View in: PubMed
    Score: 0.397
  12. Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images. J Psychopharmacol. 2012 Oct; 26(10):1289-98.
    View in: PubMed
    Score: 0.382
  13. Psychoactive drugs and false memory: comparison of dextroamphetamine and d-9-tetrahydrocannabinol on false recognition. Psychopharmacology (Berl). 2012 Jan; 219(1):15-24.
    View in: PubMed
    Score: 0.358
  14. Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers. Pharmacol Biochem Behav. 2011 Feb; 97(4):627-31.
    View in: PubMed
    Score: 0.345
  15. Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology. 2003 Jul; 28(7):1356-65.
    View in: PubMed
    Score: 0.204
  16. Impaired inhibition after delta-9-tetrahydrocannabinol in women not related to circulating estradiol levels. Pharmacol Biochem Behav. 2023 04; 225:173547.
    View in: PubMed
    Score: 0.203
  17. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans. Psychopharmacology (Berl). 2002 Jun; 161(4):331-9.
    View in: PubMed
    Score: 0.190
  18. Adolescents are more sensitive than adults to acute behavioral and cognitive effects of THC. Neuropsychopharmacology. 2022 06; 47(7):1331-1338.
    View in: PubMed
    Score: 0.187
  19. Delta-9-tetrahydrocannabinol reduces willingness to exert effort in women. Psychopharmacology (Berl). 2022 May; 239(5):1487-1497.
    View in: PubMed
    Score: 0.187
  20. Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans. Drug Alcohol Depend. 2000 Jun 01; 59(3):251-60.
    View in: PubMed
    Score: 0.167
  21. Responses to oral delta9-tetrahydrocannabinol in frequent and infrequent marijuana users. Pharmacol Biochem Behav. 1999 May; 63(1):137-42.
    View in: PubMed
    Score: 0.155
  22. Effects of expectancies on subjective responses to oral delta9-tetrahydrocannabinol. Pharmacol Biochem Behav. 1998 Feb; 59(2):287-93.
    View in: PubMed
    Score: 0.142
  23. Cannabinoid modulation of amygdala subregion functional connectivity to social signals of threat. Int J Neuropsychopharmacol. 2014 Dec 28; 18(3).
    View in: PubMed
    Score: 0.114
  24. Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking. Psychopharmacology (Berl). 2012 Oct; 223(4):489-99.
    View in: PubMed
    Score: 0.095
  25. Cannabinoid modulation of subgenual anterior cingulate cortex activation during experience of negative affect. J Neural Transm (Vienna). 2012 Jun; 119(6):701-7.
    View in: PubMed
    Score: 0.093
  26. Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana. Exp Clin Psychopharmacol. 2009 Aug; 17(4):217-25.
    View in: PubMed
    Score: 0.079
  27. Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. J Neurosci. 2008 Mar 05; 28(10):2313-9.
    View in: PubMed
    Score: 0.071
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.